Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.
获得性 CYP19A1 扩增是 ERα 转移性乳腺癌中芳香化酶抑制剂耐药性的早期特异性机制
期刊:Nature Genetics
影响因子:29
doi:10.1038/ng.3773
Magnani Luca, Frige Gianmaria, Gadaleta Raffaella Maria, Corleone Giacomo, Fabris Sonia, Kempe Mannus H, Verschure Pernette J, Barozzi Iros, Vircillo Valentina, Hong Sung-Pil, Perone Ylenia, Saini Massimo, Trumpp Andreas, Viale Giuseppe, Neri Antonino, Ali Simak, Colleoni Marco Angelo, Pruneri Giancarlo, Minucci Saverio
